- Merrimack Pharmaceuticals (NASDAQ:MACK): Q4 EPS of -$0.25 misses by $0.04.
- Revenue of $61.24M (+185.9% Y/Y) beats by $10.8M.
- Press Release
Merrimack Pharmaceuticals misses by $0.04, beats on revenue
Recommended For You
More Trending News
About MACK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MACK | - | - |
| Merrimack Pharmaceuticals, Inc. | ||